Biodistribution of [11C]PIB in Patients With Risk Factors for Alzheimer's Disease

Recruiting in Palo Alto (17 mi)

Overseen by Suzanne Craft, PhD

Age: 18+

Sex: Any

Travel: May Be Covered

Time Reimbursement: Varies

Trial Phase: Academic

Waitlist Available

Sponsor: Wake Forest University Health Sciences

No Placebo Group

Trial Summary

What is the purpose of this trial?

Participants enrolled at the Alzheimer's Disease Research Center (ADRC) at Wake Forest School of Medicine will be invited to take part in this study. The purpose of this study is to identify and measure the amount of a protein called amyloid in the brain.It is thought that the build up of amyloid may be related to the development of Alzheimer's disease.

Eligibility Criteria

Inclusion Criteria

Enrolled in a study with the Alzheimer's Disease Research Center.

Participant Groups

Find a Clinic Near You

Research Locations Nearby Select from list below to view details:

Wake Forest Baptist Medical Center Winston-Salem, NC

Who Is Running the Clinical Trial?

Wake Forest University Health Sciences Lead Sponsor

References